- Filed
- Apr 21, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 17, 2026 | 23.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 24.04M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 23.36M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $92K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $128K |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $801K |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $801K |
| Capex | Q1 2026 · Mar 31, 2026 | $1.75M |
| Capex | Q1 2026 · Mar 31, 2025 | $4.25M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $5.06M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$3.62M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $581.94M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $248.47M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $950.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $941.77M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $893.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $890.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.93B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.44B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.88B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.38B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Net Income | Q1 2026 · Mar 31, 2026 | $6.36M |
| Net Income | Q1 2026 · Mar 31, 2025 | $17K |